A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring

Clinical trial NCT06788509 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT06788509
Sponsor: Janssen Research & Development, LLC
Status: ENROLLING_BY_INVITATION
Phase: Phase 1
Study type: INTERVENTIONAL

Leukemia, Myeloid, Acute Leukemia, Lymphocytic, Chronic, B-Cell Lymphoma, Non-Hodgkin Myelodysplastic Syndromes Neoplasms Solid Tumor, Adult Prostatic Neoplasms, Castration-Resistant

Start date: 2024-12-30
Primary completion: 2028-01-19
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.